Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.38T
Revenue (ttm)	2.25T
Net Income (ttm)	66.57B
Shares Out	90.57M
EPS (ttm)	734.97
PE Ratio	95.79
Forward PE	n/a
Dividend	909.09 (1.30%)
Ex-Dividend Date	n/a

Volume	11,592
Average Volume	9,887
Open	72,500
Previous Close	72,900
Day's Range	70,000 - 72,500
52-Week Range	69,000 - 91,364
Beta	0.24
RSI	40.09
Earnings Date	Jan 22, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.